United States · Funded startup

Who invested in Point Biopharma

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$125Mraised across 1 round since 2022, from 1 source

Latest round
Round, $125MSept 2022
Investors
2
See who backed them

The rounds

  1. Sept 2022

Everyone who backed them

RA Capital ManagementPrivate equity1round
Perceptive AdvisorsAsset manager1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Point Biopharma

Who invested in Point Biopharma?

Point Biopharma's investors include RA Capital Management and Perceptive Advisors.

How much has Point Biopharma raised?

Point Biopharma has raised $125M across 1 round since 2022.

When did Point Biopharma last raise?

Point Biopharma's most recent round was an Undisclosed round of $125M in Sept 2022.

What was Point Biopharma's biggest round?

Its most recent round, $125M in Sept 2022, is also its largest on record.

Who backed Point Biopharma first?

Point Biopharma's first round on record, in Sept 2022, was backed by RA Capital Management and Perceptive Advisors.

What stage is Point Biopharma at?

Point Biopharma's latest named round is an Undisclosed round, in Sept 2022.

Where is Point Biopharma based?

Point Biopharma is based in the United States.

Companies like Point Biopharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.